NCT02444351View on ClinicalTrials.gov

Botulinum Toxin Type A Injection Into the Gastrocnemius Muscle for Treatment of Nocturnal Calf Cramps in Patients With Lumbar Spinal Stenosis

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 26, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Spinal Stenosis With Nocturnal Calf Cramps
Interventions
DRUG

botulinum toxin type A (Nabota®) injection into the gastrocnemius muscle

ultrasound-guided botulinum toxin type A (Nabota®, Daewoong co. Seoul, Korea) injection into the gastrocnemius muscle (maximum 200unit per each calf).

OTHER

no intervention

Patients in the control group will not receive any injection on the gastrocnemius muscle.

Trial Locations (1)

120-752

Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT02444351 - Botulinum Toxin Type A Injection Into the Gastrocnemius Muscle for Treatment of Nocturnal Calf Cramps in Patients With Lumbar Spinal Stenosis | Biotech Hunter | Biotech Hunter